Role of oxidative stress in diabetic nephropathy

Advances in Chronic Kidney Disease

Volumn 12, Issue 2, 2005, Pages 146-154

  Vasavada, Nina ^b   Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

Diabetes mellitus; Diabetic nephropathies; Oxidative stress; Proteinuria; Reactive oxygen species

Indexed keywords

ANTIOXIDANT ACTIVITY; BLOOD VESSEL INJURY; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; KIDNEY FUNCTION; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; TISSUE INJURY;

EID: 16844363759     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.01.001     Document Type: Article

References (85)

1. USRDS The United States Renal Data System Am J Kidney Dis 42 suppl 5 2003 1 230
2. E. Haugen, K.A. Nath The involvement of oxidative stress in the progression of renal injury Blood Purif 17 1999 58 65
3. A. Besarab, S. Frinak, J. Yee An indistinct balance The safety and efficacy of parenteral iron therapy J Am Soc Nephrol 10 1999 2029 2043
4. M.L. Onozato, A. Tojo, A. Goto Oxidative stress and nitric oxide synthase in rat diabetic nephropathy Effects of ACEI and ARB Kidney Int 61 2002 186 194
5. C. Leeuwenburgh, M.M. Hardy, S.L. Hazen Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima J Biol Chem 272 1997 1433 1436
6. C.S. Wilcox Redox regulation of the afferent arteriole and tubuloglomerular feedback Acta Physiol Scand 179 2003 217 223
7. V. Schachinger, M.B. Britten, A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
8. M. Geiszt, J.B. Kopp, P. Varnai Identification of renox, an NAD(P)H oxidase in kidney Proc Natl Acad Sci U S A 97 2000 8010 8014
9. R.K. Studer, P.A. Craven, F.R. DeRubertis Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells Metabolism 46 1997 918 925
10. A. Montero, K.A. Munger, R.Z. Khan F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes Kidney Int 58 2000 1963 1972
11. A. Aydin, H. Orhan, A. Sayal Oxidative stress and nitric oxide related parameters in type II diabetes mellitus Effects of glycemic control Clin Biochem 34 2001 65 70
12. P.A. Conz, P.A. Bevilacqua, G. La Greca Phospholipid hydroperoxide glutathione peroxidase in the normal human kidney A possible role in protecting cell membranes Exp Nephrol 1 1993 376 378
13. K.F. Petersen, S. Dufour, D. Befroy Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N Engl J Med 350 2004 664 671
14. R. Taylor Causation of type 2 diabetes--The Gordian knot unravels N Engl J Med 350 2004 639 641
15. T. Nishikawa, D. Edelstein, X.L. Du Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
16. R.P. Robertson Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes J Biol Chem 279 2004 42351 42354
17. M. Evans, R.A. Anderson, J. Graham Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus Circulation 101 2000 1773 1779
18. S.S. Chung, E.C. Ho, K.S. Lam Contribution of polyol pathway to diabetes-induced oxidative stress J Am Soc Nephrol 14 suppl 3 2003 S233 S236
19. T. Inoguchi, T. Sonta, H. Tsubouchi Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes Role of vascular NAD(P)H oxidase J Am Soc Nephrol 14 suppl 3 2003 S227 S232
20. J.M. Forbes, M.E. Cooper, M.D. Oldfield Role of advanced glycation end products in diabetic nephropathy J Am Soc Nephrol 14 suppl 3 2003 S254 S258
21. R. Marfella, L. Quagliaro, F. Nappo Acute hyperglycemia induces an oxidative stress in healthy subjects J Clin Invest 108 2001 635 636
22. R. Marfella, G. Verrazzo, R. Acampora Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects Am J Physiol 268 1995 E1167 E1173
23. K. Esposito, F. Nappo, R. Marfella Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans Role of oxidative stress Circulation 106 2002 2067 2072
24. F.B. Stentz, G.E. Umpierrez, R. Cuervo Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises Diabetes 53 2004 2079 2086
25. J.A. Miller, J.S. Floras, B. Zinman Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes Clin Sci (Lond) 90 1996 189 195
26. J.A. Miller Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus J Am Soc Nephrol 10 1999 1778 1785
27. S. Rajagopalan, S. Kurz, T. Munzel Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J Clin Invest 97 1996 1916 1923
28. C. Berry, C.A. Hamilton, M.J. Brosnan Investigation into the sources of superoxide in human blood vessels Angiotensin II increases superoxide production in human internal mammary arteries Circulation 101 2000 2206 2212
29. N.K. Gopaul, M.D. Manraj, A. Hebe Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism Diabetologia 44 2001 706 712
30. J. Helmersson, B. Vessby, A. Larsson Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population Circulation 109 2004 1729 1734
31. D. Giugliano, A. Ceriello, G. Paolisso Oxidative stress and diabetic vascular complications Diabetes Care 19 1996 257 267
32. R.A. Anderson, M.L. Evans, G.R. Ellis The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes Atherosclerosis 154 2001 475 483
33. M.I. Mackness, S. Arrol, C. Abbott Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase Atherosclerosis 104 1993 129 135
34. M. Senti, M. Tomas, M. Fito Antioxidant paraoxonase 1 activity in the metabolic syndrome J Clin Endocrinol Metab 88 2003 5422 5426
35. P. Dandona, K. Thusu, S. Cook Oxidative damage to DNA in diabetes mellitus Lancet 347 1996 444 445
36. J. Leinonen, T. Lehtimaki, S. Toyokuni New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus FEBS Lett 417 1997 150 152
37. Y. Hinokio, S. Suzuki, M. Hirai Oxidative DNA damage in diabetes mellitus Its association with diabetic complications Diabetologia 42 1999 995 998
38. I.G. Obrosova, L. Fathallah, E. Liu Early oxidative stress in the diabetic kidney Effect of DL-alpha-lipoic acid Free Radic Biol Med 34 2003 186 195
39. R. Root-Bernstein, J.V. Busik, D.N. Henry Are diabetic neuropathy, retinopathy and nephropathy caused by hyperglycemic exclusion of dehydroascorbate uptake by glucose transporters? J Theor Biol 216 2002 345 359
40. H. Goldenberg, E. Schweinzer Transport of vitamin C in animal and human cells J Bioenerg Biomembr 26 1994 359 367
41. T. Shimoike, T. Inoguchi, F. Umeda The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy Metabolism 49 2000 1030 1035
42. Y. Hinokio, S. Suzuki, M. Hirai Oxidative DNA damage in diabetes mellitus Its association with diabetic complications Diabetologia 42 1999 995 998
43. S. Mehrotra, K.L. Ling, Y. Bekele Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with type 2 diabetes mellitus Diabet Med 18 2001 109 115
44. H.F. Lopes, J.D. Morrow, M.P. Stoijiljkovic Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans Am J Hypertens 16 2003 331 336
45. G. Seghieri, P. Di Simplicio, R. Anichini Platelet antioxidant enzymes in insulin-dependent diabetes mellitus Clin Chim Acta 309 2001 19 23
46. A. Ceriello, A. Morocutti, F. Mercuri Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy Diabetes 49 2000 2170 2177
47. N. Kashihara, Y. Watanabe, H. Makino Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species Proc Natl Acad Sci U S A 89 1992 6309 6313
48. D. Suzuki, T. Miyata, N. Saotome Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions J Am Soc Nephrol 10 1999 822 832
49. C.K. Roberts, N.D. Vaziri, R.J. Barnard Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability Circulation 106 2002 2530 2532
50. P.W. Sanders Salt intake, endothelial cell signaling, and progression of kidney disease Hypertension 43 2004 142 146
51. W.Z. Ying, P.W. Sanders Dietary salt modulates renal production of transforming growth factor-beta in rats Am J Physiol 274 1998 F635 F641
52. W.Z. Ying, P.W. Sanders Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-beta1 Am J Physiol 275 1998 F18 F24
53. E.J. Lewis, L.G. Hunsicker, R.P. Bain The Collaborative Study Group The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
54. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
55. B.M. Brenner, M.E. Cooper, D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
56. H.H. Parving, H. Lehnert, J. Brochner-Mortensen The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 2001 870 878
57. S. Yusuf, P. Sleight, J. Pogue The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
58. E. Lonn, S. Yusuf, V. Dzavik Effects of ramipril and vitamin E on atherosclerosis The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) Circulation 103 2001 919 925
59. T. Munzel, J.F. Keaney Jr Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 104 2001 1571 1574
60. Y.K. Kim, M.S. Lee, S.M. Son Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes Diabetes 51 2002 522 527
61. R. Agarwal Proinflammatory effects of oxidative stress in chronic kidney disease Role of additional angiotensin II blockade Am J Physiol Renal Physiol 284 2003 F863 F869
62. F.R. Danesh, M.M. Sadeghi, N. Amro 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway Implications for diabetic nephropathy Proc Natl Acad Sci U S A 99 2002 8301 8305
63. H. Usui, K. Shikata, M. Matsuda HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats Nephrol Dial Transplant 18 2003 265 272
64. A.H. Wagner, T. Kohler, U. Ruckschloss Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler Thromb Vasc Biol 20 2000 61 69
65. K. Suzumura, E. Kasahara, Y. Ohnishi Fluvastatin normalizes the decreased turnovers of glutathione and ascorbic acid in Watanabe heritable hyperlipidaemic rabbits Clin Exp Pharmacol Physiol 27 2000 709 714
66. V. Blaha, Z. Zadak, D. Solichova Hypocholesterolemic effect of pravastatin is associated with increased content of antioxidant vitamin-E in cholesterol fractions Acta Medica (Hradec Kralove) 41 1998 87 90
67. G. Tonolo, M. Ciccarese, P. Brizzi Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment Diabetes Care 20 1997 1891 1895
68. K.S. Lam, I.K. Cheng, E.D. Janus Cholesterol-lowering therapy may retard the progression of diabetic nephropathy Diabetologia 38 1995 604 609
69. A. Ceriello, L. Quagliaro, L. Piconi Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment Diabetes 53 2004 701 710
70. D. Koya, I.K. Lee, H. Ishii Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol J Am Soc Nephrol 8 1997 426 435
71. D. Koya, K. Hayashi, M. Kitada Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats J Am Soc Nephrol 14 suppl 3 2003 S250 S253
72. D.W. Laight, K.M. Desai, N.K. Gopaul F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat Effects of vitamin E Eur J Pharmacol 377 1999 89 92
73. J.A. Beckman, A.B. Goldfine, M.B. Gordon Oral antioxidant therapy improves endothelial function in type 1 but not type 2 diabetes mellitus Am J Physiol Heart Circ Physiol 285 2003 H2392 H2398
74. A. Sharma, S. Kharb, S.N. Chugh Effect of glycemic control and vitamin E supplementation on total glutathione content in non-insulin-dependent diabetes mellitus Ann Nutr Metab 44 2000 11 13
75. S. Park, S.B. Choi Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes Am J Clin Nutr 75 2002 728 733
76. D. Darko, A. Dornhorst, F.J. Kelly Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes Clin Sci (Lond) 103 2002 339 344
77. H.H. Ting, F.K. Timimi, K.S. Boles Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus J Clin Invest 97 1996 22 28
78. J.L. Evans, I.D. Goldfine Alpha-lipoic acid A multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes Diabetes Technol Ther 2 2000 401 413
79. M.F. Melhem, P.A. Craven, J. Liachenko Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes J Am Soc Nephrol 13 2002 108 116
80. M.A. Hofmann, S. Schiekofer, B. Isermann Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB Diabetologia 42 1999 222 232
81. V. Borcea, J. Nourooz-Zadeh, S.P. Wolff Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria Free Radic Biol Med 26 1999 1495 1500
82. M. Tepel, G.M. van der, C. Schwarzfeld Prevention of radiographic- contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
83. P. Odetti, C. Pesce, N. Traverso Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 52 2003 499 505
84. S.H. Park, H.J. Choi, J.H. Lee High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-beta 1 Kidney Int 59 2001 1695 1705
85. R. Agarwal, N. Vasavada, N.G. Sachs Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease Kidney Int 65 2004 2279 2289